We recently compiled a list of the 11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now. In this article, we are ...

The stock's fall snapped a two-day winning streak.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

We recently published a list of 10 Best Safe Stocks To Buy According to Analysts. In this article, we are going to take a ...

But making AbbVie an even more interesting and timely stock to look at, is the fact that in trading on Monday, shares of ABBV ...

AbbVie has entered into a definitive agreement to acquire Nimble Therapeutics in a deal valued at $200m in cash.

AbbVie Inc. is a strong investment opportunity with promising drugs, steady dividends, and attractive growth potential. Find ...

Breast Reconstruction Market Outlook to 2031The global breast reconstruction market was valued at US$ 1.4 billion in 2021 and is projected to grow at a CAGR of 5.3% from 2022 to 2031, reaching more ...

Friday announced an agreement to acquire Nimble Therapeutics for a cash payment of $200 million at closing, along ...

AbbVie Inc (ABBV) stock saw a decline, ending the day at $173.19 which represents a decrease of $-1.18 or -0.68% from the prior close of $174.37. The stock opened at $174.91 and touched a low of $171.

Quantbot Technologies LP bought a new position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the 3rd quarter, ...